Secondary Parkinsonism Latest Advances

Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024.

Journal: NCHS data brief

Published: June 10, 2026

Reversible subacute secondary parkinsonism due to neuroborreliosis with characteristic MRI evolution.

Journal: BMJ case reports

Published: April 29, 2026

Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark design.

Journal: Diabetology & metabolic syndrome

Published: April 21, 2026

Tracking ClO- Dynamics during the Progression of Parkinson's Disease in MPTP Mouse Model Using In Vivo Brain Microdialysis.

Journal: ACS chemical neuroscience

Published: April 15, 2026

A refined chronic MPTP/probenecid model of Parkinson's disease in mature adult mice.

Journal: Experimental neurology

Published: February 23, 2026

SU-Eohyeol Pharmacopuncture Ameliorates Parkinson's Disease-Associated Pain via the CB1 and PPARγ Pathways in an MPTP-Induced Mouse Model.

Journal: Pain research & management

Published: February 19, 2026

Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 02, 2026

Icaritin ameliorates MPTP-induced Parkinson's disease model by targeting the NLRP3 inflammasome pathway.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: January 14, 2026

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Journal: Neurology

Published: January 09, 2026

Neuroprotective Effect of D-Pinitol Against MPTP-Induced Parkinsonism in C57BL/6J Mice.

Journal: Antioxidants (Basel, Switzerland)

Published: December 01, 2025

Acupuncture for Mild Cognitive Impairment in Vascular Parkinsonism: A Prospective, Randomized, Controlled Trial Protocol.

Journal: Neuropsychiatric disease and treatment

Published: December 01, 2025

The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways.

Journal: The Journal of pharmacy and pharmacology

Published: November 16, 2025

Secondary Parkinsonism Latest Advances

Find the Latest Research About Secondary Parkinsonism

Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024.

Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024.

Reversible subacute secondary parkinsonism due to neuroborreliosis with characteristic MRI evolution.

Reversible subacute secondary parkinsonism due to neuroborreliosis with characteristic MRI evolution.

Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark design.

Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark design.

Tracking ClO- Dynamics during the Progression of Parkinson's Disease in MPTP Mouse Model Using In Vivo Brain Microdialysis.

Tracking ClO- Dynamics during the Progression of Parkinson's Disease in MPTP Mouse Model Using In Vivo Brain Microdialysis.

A refined chronic MPTP/probenecid model of Parkinson's disease in mature adult mice.

A refined chronic MPTP/probenecid model of Parkinson's disease in mature adult mice.

SU-Eohyeol Pharmacopuncture Ameliorates Parkinson's Disease-Associated Pain via the CB1 and PPARγ Pathways in an MPTP-Induced Mouse Model.

SU-Eohyeol Pharmacopuncture Ameliorates Parkinson's Disease-Associated Pain via the CB1 and PPARγ Pathways in an MPTP-Induced Mouse Model.

Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4.

Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4.

Icaritin ameliorates MPTP-induced Parkinson's disease model by targeting the NLRP3 inflammasome pathway.

Icaritin ameliorates MPTP-induced Parkinson's disease model by targeting the NLRP3 inflammasome pathway.

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Neuroprotective Effect of D-Pinitol Against MPTP-Induced Parkinsonism in C57BL/6J Mice.

Neuroprotective Effect of D-Pinitol Against MPTP-Induced Parkinsonism in C57BL/6J Mice.

Acupuncture for Mild Cognitive Impairment in Vascular Parkinsonism: A Prospective, Randomized, Controlled Trial Protocol.

Acupuncture for Mild Cognitive Impairment in Vascular Parkinsonism: A Prospective, Randomized, Controlled Trial Protocol.

The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways.

The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways.